Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.

Thumbnail
URI
http://hdl.handle.net/11287/620871
Author
Tan, W.S.
Panchal, A.
Buckley, L.
Devall, A. J.
Loubière, L. S.
Pope, A. M.
Feneley, M. R.
Cresswell, J.
Issa, R.
Mostafid, H.
Madaan, S.
Bhatt, R.
McGrath, John S
Sangar, V.
Griffiths, T. R. L.
Page, T.
Hodgson, D.
Datta, S. N.
Billingham, L. J.
Kelly, J. D.
Date
2018-09-28
Journal
European urology
Type
Journal Article
Publisher
Elsevier
DOI
10.1016/j.eururo.2018.09.005
Rights
Archived with thanks to European urology
Metadata
Show full item record
Abstract
There is no effective intravesical second-line therapy for non-muscle-invasive bladder cancer (NMIBC) when bacillus Calmette-Guérin (BCG) fails.
Citation
Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial. 2019 Jan;75(1):63-71 Epub 2019 Sep 28 Eur. Urol.
Publisher URL
https://linkinghub.elsevier.com/retrieve/pii/S0302-2838(18)30655-9
Collections